NCT00154115View on ClinicalTrials.gov

Levosimendan in High Risk Heart Valve Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Heart Failure
Interventions
DRUG

levosimendan

Intravenous infusion, blus 24 mcg/kg in 30-minutes followed by 0.2 mcg/kg/min up to 24 hours

DRUG

placebo

Placebo

Trial Locations (1)

70210

Kuopio University Hospital, Kuopio

All Listed Sponsors
lead

Kuopio University Hospital

OTHER

NCT00154115 - Levosimendan in High Risk Heart Valve Surgery | Biotech Hunter | Biotech Hunter